VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q87807506 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235942.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q87807506‏
024 ‎‡a 0000-0002-1151-861X‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q87807506‏
100 0 ‎‡a Steven J Katz‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Steven J Katz‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A pilot study to increase cascade genetic testing in families with hereditary cancer syndromes.‏
670 ‎‡a Author's A population-based study of invitation to and participation in clinical trials among women with early-stage breast cancer‏
670 ‎‡a Author's Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making‏
670 ‎‡a Author's Addressing overtreatment in breast cancer: The doctors' dilemma‏
670 ‎‡a Author's Addressing Overtreatment in DCIS: What Should Physicians Do Now?‏
670 ‎‡a Author's Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer‏
670 ‎‡a Author's An informed decision? Breast cancer patients and their knowledge about treatment‏
670 ‎‡a Author's Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer‏
670 ‎‡a Author's Association of Germline Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast Cancer‏
670 ‎‡a Author's Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer‏
670 ‎‡a Author's Attitudes toward and use of cancer management guidelines in a national sample of medical oncologists and surgeons‏
670 ‎‡a Author's Breast cancer treatment experiences of Latinas in Los Angeles County‏
670 ‎‡a Author's Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer-Reply‏
670 ‎‡a Author's Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer‏
670 ‎‡a Author's Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer‏
670 ‎‡a Author's Conflicts in decision-making for breast cancer surgery‏
670 ‎‡a Author's Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer‏
670 ‎‡a Author's Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind‏
670 ‎‡a Author's Coordinating cancer care: patient and practice management processes among surgeons who treat breast cancer‏
670 ‎‡a Author's Coordination of breast cancer care between radiation oncologists and surgeons: a survey study‏
670 ‎‡a Author's Correlates of between-surgeon variation in breast cancer treatments‏
670 ‎‡a Author's Correlates of breast reconstruction: results from a population-based study‏
670 ‎‡a Author's Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction‏
670 ‎‡a Author's Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer‏
670 ‎‡a Author's Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients‏
670 ‎‡a Author's Decision-support networks of women newly diagnosed with breast cancer‏
670 ‎‡a Author's Determinants of colorectal cancer screening use, attempts, and non-use‏
670 ‎‡a Author's Development and psychometric properties of a brief measure of subjective decision quality for breast cancer treatment‏
670 ‎‡a Author's Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample‏
670 ‎‡a Author's Dissemination of Quality-of-Care Research Findings to Breast Oncology Surgeons‏
670 ‎‡a Author's Does it matter where you go for breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for breast cancer‏
670 ‎‡a Author's Does physician communication style impact patient report of decision quality for breast cancer treatment?‏
670 ‎‡a Author's Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control‏
670 ‎‡a Author's Employment of nurse practitioners and physician assistants in breast cancer care‏
670 ‎‡a Author's Evaluating a Decision Aid for Improving Decision Making in Patients with Early-stage Breast Cancer‏
670 ‎‡a Author's Factors associated with patient involvement in surgical treatment decision making for breast cancer‏
670 ‎‡a Author's Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample‏
670 ‎‡a Author's From policy to patients and back: surgical treatment decision making for patients with breast cancer‏
670 ‎‡a Author's Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer‏
670 ‎‡a Author's Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.‏
670 ‎‡a Author's Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer.‏
670 ‎‡a Author's Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients‏
670 ‎‡a Author's Guidelines Do Not Proscribe Surgeons Performing Genetic Testing-Reply‏
670 ‎‡a Author's Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer‏
670 ‎‡a Author's Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial‏
670 ‎‡a Author's Involvement of Primary Care Physicians in the Decision Making and Care of Patients With Breast Cancer‏
670 ‎‡a Author's Knowledge Regarding and Patterns of Genetic Testing in Patients Newly Diagnosed With Breast Cancer Participating in the iCanDecide Trial‏
670 ‎‡a Author's Latina patient perspectives about informed treatment decision making for breast cancer‏
670 ‎‡a Author's Latinas and breast cancer outcomes: population-based sampling, ethnic identity, and acculturation assessment‏
670 ‎‡a Author's Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries‏
670 ‎‡a Author's Margins in ductal carcinoma in situ: is bigger really better?‏
670 ‎‡a Author's Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?‏
670 ‎‡a Author's Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ‏
670 ‎‡a Author's Patient involvement in surgery treatment decisions for breast cancer‏
670 ‎‡a Author's Patient-physician shared decision making--reply‏
670 ‎‡a Author's Patient Preferences for Primary Care Provider Roles in Breast Cancer Survivorship Care‏
670 ‎‡a Author's Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer‏
670 ‎‡a Author's Patient-reported Quality of Life and Satisfaction With Cosmetic Outcomes After Breast Conservation and Mastectomy With and Without Reconstruction: Results of a Survey of Breast Cancer Survivors‏
670 ‎‡a Author's Patient satisfaction with treatment of breast cancer: does surgeon specialization matter?‏
670 ‎‡a Author's Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer.‏
670 ‎‡a Author's Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer‏
670 ‎‡a Author's Patterns and Correlates of Knowledge, Communication, and Receipt of Breast Reconstruction in a Modern Population-Based Cohort of Patients with Breast Cancer‏
670 ‎‡a Author's Patterns and correlates of local therapy for women with ductal carcinoma-in-situ‏
670 ‎‡a Author's Patterns and correlates of patient referral to surgeons for treatment of breast cancer‏
670 ‎‡a Author's Patterns of use and patient satisfaction with breast reconstruction among obese patients: results from a population-based study‏
670 ‎‡a Author's Perceptions of care coordination in a population-based sample of diverse breast cancer patients‏
670 ‎‡a Author's Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty‏
670 ‎‡a Author's Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer‏
670 ‎‡a Author's Postmastectomy Breast Reconstruction: Exploring Plastic Surgeon Practice Patterns and Perspectives‏
670 ‎‡a Author's Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process‏
670 ‎‡a Author's Preferences for Physician Roles in Follow-up Care During Survivorship: Do Patients, Primary Care Providers, and Oncologists Agree?‏
670 ‎‡a Author's Prescription drug coverage: implications for hormonal therapy adherence in women diagnosed with breast cancer‏
670 ‎‡a Author's Primary care provider-reported involvement in breast cancer treatment decisions‏
670 ‎‡a Author's Primary Care Providers' Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions‏
670 ‎‡a Author's Provider Involvement in Care During Initial Cancer Treatment and Patient Preferences for Provider Roles After Initial Treatment‏
670 ‎‡a Author's Providers of follow-up care in a population-based sample of breast cancer survivors‏
670 ‎‡a Author's Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study‏
670 ‎‡a Author's Racial and ethnic variation in partner perspectives about the breast cancer treatment decision-making experience‏
670 ‎‡a Author's Racial/ethnic differences in adequacy of information and support for women with breast cancer‏
670 ‎‡a Author's Racial/ethnic differences in job loss for women with breast cancer‏
670 ‎‡a Author's Racial/ethnic differences in quality of life after diagnosis of breast cancer‏
670 ‎‡a Author's Racial/ethnic disparities in knowledge about risks and benefits of breast cancer treatment: does it matter where you go?‏
670 ‎‡a Author's Receipt of delayed breast reconstruction after mastectomy: do women revisit the decision?‏
670 ‎‡a Author's Recent trends in chemotherapy use and oncologists' treatment recommendations for early-stage breast cancer‏
670 ‎‡a Author's Recurrence risk perception and quality of life following treatment of breast cancer‏
670 ‎‡a Author's Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.‏
670 ‎‡a Author's Reply to K. Lisy et al.‏
670 ‎‡a Author's Reply to S.M. Sorscher and A.B. Hafeez Bhatti.‏
670 ‎‡a Author's Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer‏
670 ‎‡a Author's Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences‏
670 ‎‡a Author's Social and Clinical Determinants of Contralateral Prophylactic Mastectomy‏
670 ‎‡a Author's Study protocol: A Randomized Controlled Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool‏
670 ‎‡a Author's Study protocol: A Randomized Controlled Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool (iCanDecide).‏
670 ‎‡a Author's Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer‏
670 ‎‡a Author's Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer‏
670 ‎‡a Author's Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy For Women With Breast Cancer‏
670 ‎‡a Author's Surgeon-level variation in patients' appraisals of their breast cancer treatment experiences‏
670 ‎‡a Author's Surgeon perspectives about local therapy for breast carcinoma‏
670 ‎‡a Author's Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer‏
670 ‎‡a Author's Surgeons' knowledge and practices regarding the role of radiation therapy in breast cancer management‏
670 ‎‡a Author's Symptom experience and quality of life of women following breast cancer treatment‏
670 ‎‡a Author's The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients‏
670 ‎‡a Author's The challenge of developing quality measures for breast cancer surgery‏
670 ‎‡a Author's The challenge of individualizing treatments for patients with breast cancer‏
670 ‎‡a Author's The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence‏
670 ‎‡a Author's The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis‏
670 ‎‡a Author's The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients‏
670 ‎‡a Author's The influence of age on the breast surgery decision-making process‏
670 ‎‡a Author's The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy‏
670 ‎‡a Author's The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis‏
670 ‎‡a Author's The value of sharing treatment decision making with patients: expecting too much?‏
670 ‎‡a Author's Treatment-associated toxicities reported by patients with early-stage invasive breast cancer‏
670 ‎‡a Author's Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations‏
670 ‎‡a Author's Treatment decisions and employment of breast cancer patients: Results of a population-based survey‏
670 ‎‡a Author's Treatment experiences of Latinas after diagnosis of breast cancer.‏
670 ‎‡a Author's Trend Analysis on Reoperation After Lumpectomy for Breast Cancer-Reply.‏
670 ‎‡a Author's Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management‏
670 ‎‡a Author's Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data‏
670 ‎‡a Author's Understanding the engagement of key decision support persons in patient decision making around breast cancer treatment‏
670 ‎‡a Author's Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer‏
670 ‎‡a Author's Undissected Axilla and Axillary Radiotherapy-In Reply‏
670 ‎‡a Author's Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer‏
670 ‎‡a Author's Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer‏
670 ‎‡a Author's Use of Online Communication by Patients With Newly Diagnosed Breast Cancer During the Treatment Decision Process‏
670 ‎‡a Author's Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer‏
670 ‎‡a Author's What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?‏
670 ‎‡a Author's What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates‏
670 ‎‡a Author's ラティーナと nhũ がんの転 quy: Nhân khẩu ベースのサンプリング, dân tộc đích アイデンティティ, および văn hóa 変 dung の bình 価‏
909 ‎‡a (orcid) 000000021151861x‏ ‎‡9 1‏
919 ‎‡a latinasandbreastcanceroutcomespopulationbasedsamplingethnicidentityandacculturationassessment‏ ‎‡A Latinas and breast cancer outcomes: population-based sampling, ethnic identity, and acculturation assessment‏ ‎‡9 1‏
919 ‎‡a longtermfinancialburdenofbreastcancerexperiencesofadiversecohortofsurvivorsidentifiedthroughpopulationbasedregistries‏ ‎‡A Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries‏ ‎‡9 1‏
919 ‎‡a marginsinductalcarcinomainsituisbiggerreallybetter‏ ‎‡A Margins in ductal carcinoma in situ: is bigger really better?‏ ‎‡9 1‏
919 ‎‡a oncologistsinfluenceonreceiptofadjuvantchemotherapydoesitmatterwhomyouseefortreatmentofcurablebreastcancer‏ ‎‡A Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?‏ ‎‡9 1‏
919 ‎‡a patientexperiencesandclinicianviewsontheroleofradiationtherapyforductalcarcinomainsitu‏ ‎‡A Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ‏ ‎‡9 1‏
919 ‎‡a patientinvolvementinsurgerytreatmentdecisionsforbreastcancer‏ ‎‡A Patient involvement in surgery treatment decisions for breast cancer‏ ‎‡9 1‏
919 ‎‡a patientphysicianshareddecisionmakingreply‏ ‎‡A Patient-physician shared decision making--reply‏ ‎‡9 1‏
919 ‎‡a patientpreferencesforprimarycareproviderrolesinbreastcancersurvivorshipcare‏ ‎‡A Patient Preferences for Primary Care Provider Roles in Breast Cancer Survivorship Care‏ ‎‡9 1‏
919 ‎‡a patientreactionstosurgeonrecommendationsaboutcontralateralprophylacticmastectomyfortreatmentofbreastcancer‏ ‎‡A Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer‏ ‎‡9 1‏
919 ‎‡a patientreportedqualityoflifeandsatisfactionwithcosmeticoutcomesafterbreastconservationandmastectomywithandwithoutreconstructionresultsofasurveyofbreastcancersurvivors‏ ‎‡A Patient-reported Quality of Life and Satisfaction With Cosmetic Outcomes After Breast Conservation and Mastectomy With and Without Reconstruction: Results of a Survey of Breast Cancer Survivors‏ ‎‡9 1‏
919 ‎‡a patientsatisfactionwithtreatmentofbreastcancerdoessurgeonspecializationmatter‏ ‎‡A Patient satisfaction with treatment of breast cancer: does surgeon specialization matter?‏ ‎‡9 1‏
919 ‎‡a patientviewsandcorrelatesofradiotherapyomissioninapopulationbasedsampleofolderwomenwithfavorableprognosisbreastcancer‏ ‎‡A Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer.‏ ‎‡9 1‏
919 ‎‡a patternsandcorrelatesofadjuvantradiotherapyreceiptafterlumpectomyandaftermastectomyforbreastcancer‏ ‎‡A Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer‏ ‎‡9 1‏
919 ‎‡a patternsandcorrelatesofknowledgecommunicationandreceiptofbreastreconstructioninamodernpopulationbasedcohortofpatientswithbreastcancer‏ ‎‡A Patterns and Correlates of Knowledge, Communication, and Receipt of Breast Reconstruction in a Modern Population-Based Cohort of Patients with Breast Cancer‏ ‎‡9 1‏
919 ‎‡a patternsandcorrelatesoflocaltherapyforwomenwithductalcarcinomainsitu‏ ‎‡A Patterns and correlates of local therapy for women with ductal carcinoma-in-situ‏ ‎‡9 1‏
919 ‎‡a patternsandcorrelatesofpatientreferraltosurgeonsfortreatmentofbreastcancer‏ ‎‡A Patterns and correlates of patient referral to surgeons for treatment of breast cancer‏ ‎‡9 1‏
919 ‎‡a patternsofuseandpatientsatisfactionwithbreastreconstructionamongobesepatientsresultsfromapopulationbasedstudy‏ ‎‡A Patterns of use and patient satisfaction with breast reconstruction among obese patients: results from a population-based study‏ ‎‡9 1‏
919 ‎‡a perceptionsofcarecoordinationinapopulationbasedsampleofdiversebreastcancerpatients‏ ‎‡A Perceptions of care coordination in a population-based sample of diverse breast cancer patients‏ ‎‡9 1‏
919 ‎‡a physicianattitudesaboutcostconsciousnessforbreastcancertreatmentdifferencesbycancersubspecialty‏ ‎‡A Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty‏ ‎‡9 1‏
919 ‎‡a populationbasedstudyoftherelationshipoftreatmentandsociodemographicsonqualityoflifeforearlystagebreastcancer‏ ‎‡A Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer‏ ‎‡9 1‏
919 ‎‡a postmastectomybreastreconstructionexploringplasticsurgeonpracticepatternsandperspectives‏ ‎‡A Postmastectomy Breast Reconstruction: Exploring Plastic Surgeon Practice Patterns and Perspectives‏ ‎‡9 1‏
919 ‎‡a postmastectomyradiotherapyforbreastcancerpatternscorrelatescommunicationandinsightsintothedecisionprocess‏ ‎‡A Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process‏ ‎‡9 1‏
919 ‎‡a preferencesforphysicianrolesinfollowupcareduringsurvivorshipdopatientsprimarycareprovidersandoncologistsagree‏ ‎‡A Preferences for Physician Roles in Follow-up Care During Survivorship: Do Patients, Primary Care Providers, and Oncologists Agree?‏ ‎‡9 1‏
919 ‎‡a prescriptiondrugcoverageimplicationsforhormonaltherapyadherenceinwomendiagnosedwithbreastcancer‏ ‎‡A Prescription drug coverage: implications for hormonal therapy adherence in women diagnosed with breast cancer‏ ‎‡9 1‏
919 ‎‡a primarycareproviderreportedinvolvementinbreastcancertreatmentdecisions‏ ‎‡A Primary care provider-reported involvement in breast cancer treatment decisions‏ ‎‡9 1‏
919 ‎‡a primarycareprovidersperceptionsaboutparticipatinginlowriskprostatecancertreatmentdecisions‏ ‎‡A Primary Care Providers' Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions‏ ‎‡9 1‏
919 ‎‡a providerinvolvementincareduringinitialcancertreatmentandpatientpreferencesforproviderrolesafterinitialtreatment‏ ‎‡A Provider Involvement in Care During Initial Cancer Treatment and Patient Preferences for Provider Roles After Initial Treatment‏ ‎‡9 1‏
919 ‎‡a providersoffollowupcareinapopulationbasedsampleofbreastcancersurvivors‏ ‎‡A Providers of follow-up care in a population-based sample of breast cancer survivors‏ ‎‡9 1‏
919 ‎‡a racialandethnicdisparitiesintheuseofpostmastectomybreastreconstructionresultsfromapopulationbasedstudy‏ ‎‡A Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study‏ ‎‡9 1‏
919 ‎‡a racialandethnicvariationinpartnerperspectivesaboutthebreastcancertreatmentdecisionmakingexperience‏ ‎‡A Racial and ethnic variation in partner perspectives about the breast cancer treatment decision-making experience‏ ‎‡9 1‏
919 ‎‡a racialethnicdifferencesinadequacyofinformationandsupportforwomenwithbreastcancer‏ ‎‡A Racial/ethnic differences in adequacy of information and support for women with breast cancer‏ ‎‡9 1‏
919 ‎‡a racialethnicdifferencesinjoblossforwomenwithbreastcancer‏ ‎‡A Racial/ethnic differences in job loss for women with breast cancer‏ ‎‡9 1‏
919 ‎‡a racialethnicdifferencesinqualityoflifeafterdiagnosisofbreastcancer‏ ‎‡A Racial/ethnic differences in quality of life after diagnosis of breast cancer‏ ‎‡9 1‏
919 ‎‡a racialethnicdisparitiesinknowledgeaboutrisksandbenefitsofbreastcancertreatmentdoesitmatterwhereyou5‏ ‎‡A Racial/ethnic disparities in knowledge about risks and benefits of breast cancer treatment: does it matter where you go?‏ ‎‡9 1‏
919 ‎‡a receiptofdelayedbreastreconstructionaftermastectomydowomenrevisitthedecision‏ ‎‡A Receipt of delayed breast reconstruction after mastectomy: do women revisit the decision?‏ ‎‡9 1‏
919 ‎‡a recenttrendsinchemotherapyuseandoncologiststreatmentrecommendationsforearlystagebreastcancer‏ ‎‡A Recent trends in chemotherapy use and oncologists' treatment recommendations for early-stage breast cancer‏ ‎‡9 1‏
919 ‎‡a recurrenceriskperceptionandqualityoflifefollowingtreatmentofbreastcancer‏ ‎‡A Recurrence risk perception and quality of life following treatment of breast cancer‏ ‎‡9 1‏
919 ‎‡a reducingovertreatmentofcancerwithprecisionmedicinejustwhatthedoctorordered‏ ‎‡A Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.‏ ‎‡9 1‏
919 ‎‡a replytoklisyetal‏ ‎‡A Reply to K. Lisy et al.‏ ‎‡9 1‏
919 ‎‡a replytos1000sorscherandabhafeezbhatti‏ ‎‡A Reply to S.M. Sorscher and A.B. Hafeez Bhatti.‏ ‎‡9 1‏
919 ‎‡a satisfactionwithsurgeryoutcomesandthedecisionprocessinapopulationbasedsampleofwomenwithbreastcancer‏ ‎‡A Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer‏ ‎‡9 1‏
919 ‎‡a 2opinionsfrommedicaloncologistsforearlystagebreastcancerprevalencecorrelatesandconsequences‏ ‎‡A Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences‏ ‎‡9 1‏
919 ‎‡a involvementofprimarycarephysiciansinthedecisionmakingandcareofpatientswithbreastcancer‏ ‎‡A Involvement of Primary Care Physicians in the Decision Making and Care of Patients With Breast Cancer‏ ‎‡9 1‏
919 ‎‡a improvingbreastcancersurgicaltreatmentdecisionmakingtheicandeciderandomizedclinicaltrial‏ ‎‡A Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial‏ ‎‡9 1‏
919 ‎‡a impactofadjuvantchemotherapyonlongtermemploymentofsurvivorsofearlystagebreastcancer‏ ‎‡A Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer‏ ‎‡9 1‏
919 ‎‡a guidelinesdonotproscribesurgeonsperforminggenetictestingreply‏ ‎‡A Guidelines Do Not Proscribe Surgeons Performing Genetic Testing-Reply‏ ‎‡9 1‏
919 ‎‡a genetictestingandresultsinapopulationbasedcohortofbreastcancerpatientsandovariancancerpatients‏ ‎‡A Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients‏ ‎‡9 1‏
919 ‎‡a genetictestingandcounselingamongpatientswithnewlydiagnosedbreastcancer‏ ‎‡A Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer.‏ ‎‡9 1‏
919 ‎‡a gapsinreceiptofclinicallyindicatedgeneticcounselingafterdiagnosisofbreastcancer‏ ‎‡A Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.‏ ‎‡9 1‏
919 ‎‡a gapsinincorporatinggermlinegenetictestingintotreatmentdecisionmakingforearlystagebreastcancer‏ ‎‡A Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer‏ ‎‡9 1‏
919 ‎‡a frompolicytopatientsandbacksurgicaltreatmentdecisionmakingforpatientswithbreastcancer‏ ‎‡A From policy to patients and back: surgical treatment decision making for patients with breast cancer‏ ‎‡9 1‏
919 ‎‡a socialandclinicaldeterminantsofcontralateralprophylacticmastectomy‏ ‎‡A Social and Clinical Determinants of Contralateral Prophylactic Mastectomy‏ ‎‡9 1‏
919 ‎‡a factorsassociatedwithreceiptofbreastcanceradjuvantchemotherapyinadiversepopulationbasedsample‏ ‎‡A Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample‏ ‎‡9 1‏
919 ‎‡a studyprotocolarandomizedcontrolledtrialofacomprehensivebreastcancertreatmentpatientdecisiontool‏ ‎‡A Study protocol: A Randomized Controlled Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool‏ ‎‡9 1‏
919 ‎‡a factorsassociatedwithpatientinvolvementinsurgicaltreatmentdecisionmakingforbreastcancer‏ ‎‡A Factors associated with patient involvement in surgical treatment decision making for breast cancer‏ ‎‡9 1‏
919 ‎‡a studyprotocolarandomizedcontrolledtrialofacomprehensivebreastcancertreatmentpatientdecisiontoolicandecide‏ ‎‡A Study protocol: A Randomized Controlled Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool (iCanDecide).‏ ‎‡9 1‏
919 ‎‡a evaluatingadecisionaidforimprovingdecisionmakinginpatientswithearlystagebreastcancer‏ ‎‡A Evaluating a Decision Aid for Improving Decision Making in Patients with Early-stage Breast Cancer‏ ‎‡9 1‏
919 ‎‡a surgeonattitudesanduseofmriinpatientsnewlydiagnosedwithbreastcancer‏ ‎‡A Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer‏ ‎‡9 1‏
919 ‎‡a employmentofnursepractitionersandphysicianassistantsinbreastcancercare‏ ‎‡A Employment of nurse practitioners and physician assistants in breast cancer care‏ ‎‡9 1‏
919 ‎‡a surgeonattitudestowardtheomissionofaxillarydissectioninearlybreastcancer‏ ‎‡A Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer‏ ‎‡9 1‏
919 ‎‡a emergingopportunityofcascadegenetictestingforpopulationwidecancerpreventionandcontrol‏ ‎‡A Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control‏ ‎‡9 1‏
919 ‎‡a surgeoninfluenceonvariationinreceiptofcontralateralprophylacticmastectomyforwomenwithbreastcancer‏ ‎‡A Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy For Women With Breast Cancer‏ ‎‡9 1‏
919 ‎‡a surgeonlevelvariationinpatientsappraisalsoftheirbreastcancertreatmentexperiences‏ ‎‡A Surgeon-level variation in patients' appraisals of their breast cancer treatment experiences‏ ‎‡9 1‏
919 ‎‡a surgeonperspectivesaboutlocaltherapyforbreastcarcinoma‏ ‎‡A Surgeon perspectives about local therapy for breast carcinoma‏ ‎‡9 1‏
919 ‎‡a surgeonrecommendationsandreceiptofmastectomyfortreatmentofbreastcancer‏ ‎‡A Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer‏ ‎‡9 1‏
919 ‎‡a surgeonsknowledgeandpracticesregardingtheroleofradiationtherapyinbreastcancermanagement‏ ‎‡A Surgeons' knowledge and practices regarding the role of radiation therapy in breast cancer management‏ ‎‡9 1‏
919 ‎‡a symptomexperienceandqualityoflifeofwomenfollowingbreastcancertreatment‏ ‎‡A Symptom experience and quality of life of women following breast cancer treatment‏ ‎‡9 1‏
919 ‎‡a doesphysiciancommunicationstyleimpactpatientreportofdecisionqualityforbreastcancertreatment‏ ‎‡A Does physician communication style impact patient report of decision quality for breast cancer treatment?‏ ‎‡9 1‏
919 ‎‡a doesitmatterwhereyou5forbreastsurgeryattendingsurgeonsinfluenceonvariationinreceiptofmastectomyforbreastcancer‏ ‎‡A Does it matter where you go for breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for breast cancer‏ ‎‡9 1‏
919 ‎‡a disseminationofqualityofcareresearchfindingstobreastoncologysurgeons‏ ‎‡A Dissemination of Quality-of-Care Research Findings to Breast Oncology Surgeons‏ ‎‡9 1‏
919 ‎‡a discordancebetweenoriginalandcentrallaboratoriesinerandher2resultsinadiversepopulationbasedsample‏ ‎‡A Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample‏ ‎‡9 1‏
919 ‎‡a developmentandpsychometricpropertiesofabriefmeasureofsubjectivedecisionqualityforbreastcancertreatment‏ ‎‡A Development and psychometric properties of a brief measure of subjective decision quality for breast cancer treatment‏ ‎‡9 1‏
919 ‎‡a determinantsofcolorectalcancerscreeninguseattemptsandnonuse‏ ‎‡A Determinants of colorectal cancer screening use, attempts, and non-use‏ ‎‡9 1‏
919 ‎‡a associationbetweenpatientattitudesandvaluesandthestrengthofconsiderationforcontralateralprophylacticmastectomyinapopulationbasedsampleofbreastcancerpatients‏ ‎‡A The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients‏ ‎‡9 1‏
919 ‎‡a challengeofdevelopingqualitymeasuresforbreastcancersurgery‏ ‎‡A The challenge of developing quality measures for breast cancer surgery‏ ‎‡9 1‏
919 ‎‡a challengeofindividualizingtreatmentsforpatientswithbreastcancer‏ ‎‡A The challenge of individualizing treatments for patients with breast cancer‏ ‎‡9 1‏
919 ‎‡a impactofdoctorpatientcommunicationonpatientsperceptionsoftheirriskofbreastcancerrecurrence‏ ‎‡A The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence‏ ‎‡9 1‏
919 ‎‡a decisionsupportnetworksofwomennewlydiagnosedwithbreastcancer‏ ‎‡A Decision-support networks of women newly diagnosed with breast cancer‏ ‎‡9 1‏
919 ‎‡a decisioninvolvementandreceiptofmastectomyamongraciallyandethnicallydiversebreastcancerpatients‏ ‎‡A Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients‏ ‎‡9 1‏
919 ‎‡a correlatesofworryaboutrecurrenceinamultiethnicpopulationbasedsampleofwomenwithbreastcancer‏ ‎‡A Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer‏ ‎‡9 1‏
919 ‎‡a impactofsociodemographictreatmentandworksupportonmissedworkafterbreastcancerdiagnosis‏ ‎‡A The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis‏ ‎‡9 1‏
919 ‎‡a correlatesofreferralpracticesofgeneralsurgeonstoplasticsurgeonsformastectomyreconstruction‏ ‎‡A Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction‏ ‎‡9 1‏
919 ‎‡a influenceof21generecurrencescoreassayonchemotherapyuseinapopulationbasedsampleofbreastcancerpatients‏ ‎‡A The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients‏ ‎‡9 1‏
919 ‎‡a correlatesofbreastreconstructionresultsfromapopulationbasedstudy‏ ‎‡A Correlates of breast reconstruction: results from a population-based study‏ ‎‡9 1‏
919 ‎‡a influenceofageonthebreastsurgerydecisionmakingprocess‏ ‎‡A The influence of age on the breast surgery decision-making process‏ ‎‡9 1‏
919 ‎‡a correlatesofbetweensurgeonvariationinbreastcancertreatments‏ ‎‡A Correlates of between-surgeon variation in breast cancer treatments‏ ‎‡9 1‏
919 ‎‡a influenceofnonclinicalpatientfactorsonmedicaloncologistsdecisionstorecommendbreastcanceradjuvantchemotherapy‏ ‎‡A The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy‏ ‎‡9 1‏
919 ‎‡a coordinationofbreastcancercarebetweenradiationoncologistsandsurgeonsasurveystudy‏ ‎‡A Coordination of breast cancer care between radiation oncologists and surgeons: a survey study‏ ‎‡9 1‏
919 ‎‡a influenceofraceethnicityandindividualsocioeconomicfactorsonbreastcancerstageatdiagnosis‏ ‎‡A The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis‏ ‎‡9 1‏
919 ‎‡a coordinatingcancercarepatientandpracticemanagementprocessesamongsurgeonswhotreatbreastcancer‏ ‎‡A Coordinating cancer care: patient and practice management processes among surgeons who treat breast cancer‏ ‎‡9 1‏
919 ‎‡a valueofsharingtreatmentdecisionmakingwithpatientsexpectingtoomuch‏ ‎‡A The value of sharing treatment decision making with patients: expecting too much?‏ ‎‡9 1‏
919 ‎‡a contralateralprophylacticmastectomyforbreastcanceraddressingpeaceofmind‏ ‎‡A Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind‏ ‎‡9 1‏
919 ‎‡a treatmentassociatedtoxicitiesreportedbypatientswithearlystageinvasivebreastcancer‏ ‎‡A Treatment-associated toxicities reported by patients with early-stage invasive breast cancer‏ ‎‡9 1‏
919 ‎‡a contralateralprophylacticmastectomydecisionsinapopulationbasedsampleofpatientswithearlystagebreastcancer‏ ‎‡A Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer‏ ‎‡9 1‏
919 ‎‡a treatmentdecisionmakingandgenetictestingforbreastcancermainstreamingmutations‏ ‎‡A Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations‏ ‎‡9 1‏
919 ‎‡a conflictsindecisionmakingforbreastcancersurgery‏ ‎‡A Conflicts in decision-making for breast cancer surgery‏ ‎‡9 1‏
919 ‎‡a concernsaboutcancerriskandexperienceswithgenetictestinginadiversepopulationofpatientswithbreastcancer‏ ‎‡A Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer‏ ‎‡9 1‏
919 ‎‡a treatmentdecisionsandemploymentofbreastcancerpatientsresultsofapopulationbasedsurvey‏ ‎‡A Treatment decisions and employment of breast cancer patients: Results of a population-based survey‏ ‎‡9 1‏
919 ‎‡a treatmentexperiencesoflatinasafterdiagnosisofbreastcancer‏ ‎‡A Treatment experiences of Latinas after diagnosis of breast cancer.‏ ‎‡9 1‏
919 ‎‡a trendanalysisonreoperationafterlumpectomyforbreastcancerreply‏ ‎‡A Trend Analysis on Reoperation After Lumpectomy for Breast Cancer-Reply.‏ ‎‡9 1‏
919 ‎‡a trendsinreoperationafterinitiallumpectomyforbreastcanceraddressingovertreatmentinsurgicalmanagement‏ ‎‡A Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management‏ ‎‡9 1‏
919 ‎‡a underascertainmentofradiotherapyreceiptinsurveillanceepidemiologyandendresultsregistrydata‏ ‎‡A Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data‏ ‎‡9 1‏
919 ‎‡a understandingtheengagementofkeydecisionsupportpersonsinpatientdecisionmakingaroundbreastcancertreatment‏ ‎‡A Understanding the engagement of key decision support persons in patient decision making around breast cancer treatment‏ ‎‡9 1‏
919 ‎‡a understandingtheimpactofbreastreconstructiononthesurgicaldecisionmakingprocessforbreastcancer‏ ‎‡A Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer‏ ‎‡9 1‏
919 ‎‡a undissectedaxillaandaxillaryradiotherapyinreply‏ ‎‡A Undissected Axilla and Axillary Radiotherapy-In Reply‏ ‎‡9 1‏
919 ‎‡a unmetneedforclinicianengagementregardingfinancialtoxicityafterdiagnosisofbreastcancer‏ ‎‡A Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer‏ ‎‡9 1‏
919 ‎‡a uptakeresultsandoutcomesofgermlinemultiplegenesequencingafterdiagnosisofbreastcancer‏ ‎‡A Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer‏ ‎‡9 1‏
919 ‎‡a useofonlinecommunicationbypatientswithnewlydiagnosedbreastcancerduringthetreatmentdecisionprocess‏ ‎‡A Use of Online Communication by Patients With Newly Diagnosed Breast Cancer During the Treatment Decision Process‏ ‎‡9 1‏
919 ‎‡a useofpalliativeradiotherapyamongpatientswithmetastaticnonsmallcelllungcancer‏ ‎‡A Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer‏ ‎‡9 1‏
919 ‎‡a whatfactorsinfluencewomensperceptionsoftheirsystemicrecurrenceriskafterbreastcancertreatment‏ ‎‡A What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?‏ ‎‡9 1‏
919 ‎‡a chemotherapydecisionsandpatientexperiencewiththerecurrencescoreassayforearlystagebreastcancer‏ ‎‡A Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer‏ ‎‡9 1‏
919 ‎‡a whatisanadequatemarginforbreastconservingsurgerysurgeonattitudesandcorrelates‏ ‎‡A What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates‏ ‎‡9 1‏
919 ‎‡a ラティナと nhũ かんの転 quy nhân khẩu ヘスのサンフリンク dân tộc đích アイテンティティおよひ㒚 hóa biến dung の bình giới ‏ ‎‡A ラティーナと nhũ がんの転 quy: Nhân khẩu ベースのサンプリング, dân tộc đích アイデンティティ, および văn hóa 変 dung の bình 価‏ ‎‡9 1‏
919 ‎‡a cancerriskestimatesforstudyofmultiplegenetestingafterdiagnosisofbreastcancerreply‏ ‎‡A Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer-Reply‏ ‎‡9 1‏
919 ‎‡a breastcancertreatmentexperiencesoflatinasinlosangelescounty‏ ‎‡A Breast cancer treatment experiences of Latinas in Los Angeles County‏ ‎‡9 1‏
919 ‎‡a attitudestowardanduseofcancermanagementguidelinesinanationalsampleofmedicaloncologistsandsurgeons‏ ‎‡A Attitudes toward and use of cancer management guidelines in a national sample of medical oncologists and surgeons‏ ‎‡9 1‏
919 ‎‡a associationofgermlinegenetictestingresultswithlocoregionalandsystemictherapyinpatientswithbreastcancer‏ ‎‡A Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer‏ ‎‡9 1‏
919 ‎‡a associationofgermlinegenetictesttypeandresultswithpatientcancerworryafterdiagnosisofbreastcancer‏ ‎‡A Association of Germline Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast Cancer‏ ‎‡9 1‏
919 ‎‡a associationofattendingsurgeonwithvariationinthereceiptofgenetictestingafterdiagnosisofbreastcancer‏ ‎‡A Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer‏ ‎‡9 1‏
919 ‎‡a informeddecisionbreastcancerpatientsandtheirknowledgeabouttreatment‏ ‎‡A An informed decision? Breast cancer patients and their knowledge about treatment‏ ‎‡9 1‏
919 ‎‡a adjuvantendocrinetherapyinitiationandpersistenceinadiversesampleofpatientswithbreastcancer‏ ‎‡A Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer‏ ‎‡9 1‏
919 ‎‡a addressingovertreatmentindciswhatshouldphysiciansdonow‏ ‎‡A Addressing Overtreatment in DCIS: What Should Physicians Do Now?‏ ‎‡9 1‏
919 ‎‡a addressingovertreatmentinbreastcancerthedoctorsdilemma‏ ‎‡A Addressing overtreatment in breast cancer: The doctors' dilemma‏ ‎‡9 1‏
919 ‎‡a accesstobreastreconstructionaftermastectomyandpatientperspectivesonreconstructiondecisionmaking‏ ‎‡A Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making‏ ‎‡9 1‏
919 ‎‡a populationbasedstudyofinvitationtoandparticipationinclinicaltrialsamongwomenwithearlystagebreastcancer‏ ‎‡A A population-based study of invitation to and participation in clinical trials among women with early-stage breast cancer‏ ‎‡9 1‏
919 ‎‡a pilotstudytoincreasecascadegenetictestinginfamilieswithhereditarycancersyndromes‏ ‎‡A A pilot study to increase cascade genetic testing in families with hereditary cancer syndromes.‏ ‎‡9 1‏
919 ‎‡a knowledgeregardingandpatternsofgenetictestinginpatientsnewlydiagnosedwithbreastcancerparticipatingintheicandecidetrial‏ ‎‡A Knowledge Regarding and Patterns of Genetic Testing in Patients Newly Diagnosed With Breast Cancer Participating in the iCanDecide Trial‏ ‎‡9 1‏
919 ‎‡a latinapatientperspectivesaboutinformedtreatmentdecisionmakingforbreastcancer‏ ‎‡A Latina patient perspectives about informed treatment decision making for breast cancer‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 J9U|987007275309605171‏
996 ‎‡2 NLA|000035654783‏
996 ‎‡2 LC|n 2009029579‏
996 ‎‡2 LC|no2010031524‏
996 ‎‡2 NTA|073557714‏
996 ‎‡2 UAE|Mill_a10001542‏
996 ‎‡2 BNE|XX1105305‏
996 ‎‡2 BNF|14014693‏
996 ‎‡2 SUDOC|112867383‏
996 ‎‡2 LC|n 94073962‏
996 ‎‡2 SUDOC|159134773‏
996 ‎‡2 ISNI|0000000035430351‏
996 ‎‡2 DBC|87097969545300‏
996 ‎‡2 ISNI|000000010917075X‏
996 ‎‡2 NDL|00548584‏
996 ‎‡2 ISNI|0000000077636841‏
996 ‎‡2 BNF|14527963‏
996 ‎‡2 BIBSYS|13014668‏
996 ‎‡2 NKC|zmp2016925686‏
996 ‎‡2 LC|n 97003043‏
996 ‎‡2 BNF|15551902‏
996 ‎‡2 LC|no2010036747‏
996 ‎‡2 J9U|987007318463905171‏
996 ‎‡2 BNF|15551900‏
996 ‎‡2 ISNI|0000000109974571‏
996 ‎‡2 BIBSYS|90829975‏
996 ‎‡2 NUKAT|n 2007122837‏
996 ‎‡2 NUKAT|n 2014081447‏
996 ‎‡2 BNF|14628488‏
996 ‎‡2 LC|n 2005180521‏
996 ‎‡2 LC|n 94067893‏
996 ‎‡2 LC|n 94082857‏
996 ‎‡2 ISNI|0000000399656212‏
996 ‎‡2 ISNI|0000000120595484‏
996 ‎‡2 SUDOC|175847207‏
996 ‎‡2 NKC|xx0085398‏
996 ‎‡2 NKC|xx0310216‏
996 ‎‡2 J9U|987007447340205171‏
996 ‎‡2 SUDOC|197679129‏
996 ‎‡2 RERO|A008902083‏
996 ‎‡2 ERRR|12369925‏
996 ‎‡2 NUKAT|n 00013712‏
996 ‎‡2 LC|no2021134134‏
996 ‎‡2 PLWABN|9810577093105606‏
996 ‎‡2 LC|no2010018156‏
996 ‎‡2 LC|no2013004441‏
996 ‎‡2 DNB|13241788X‏
996 ‎‡2 NSK|000149191‏
996 ‎‡2 SIMACOB|27116387‏
996 ‎‡2 RERO|A003444671‏
996 ‎‡2 LC|n 91043232‏
996 ‎‡2 ISNI|0000000372596088‏
996 ‎‡2 SUDOC|028798155‏
996 ‎‡2 B2Q|0000026883‏
996 ‎‡2 NSK|000704899‏
996 ‎‡2 LC|no2010030910‏
996 ‎‡2 LC|n 82037005‏
996 ‎‡2 NTA|069424748‏
996 ‎‡2 LC|n 50044667‏
996 ‎‡2 RERO|A005554931‏
996 ‎‡2 ISNI|0000000426652656‏
996 ‎‡2 BIBSYS|90181400‏
996 ‎‡2 BNC|981058615305806706‏
996 ‎‡2 LC|n 87148207‏
996 ‎‡2 DNB|1344541267‏
996 ‎‡2 ISNI|0000000081333384‏
996 ‎‡2 NII|DA12535559‏
996 ‎‡2 LNB|LNC10-000097200‏
996 ‎‡2 BNC|981060960662306706‏
996 ‎‡2 ISNI|0000000034773993‏
996 ‎‡2 LC|n 85356110‏
996 ‎‡2 SUDOC|074480324‏
996 ‎‡2 RERO|A023308035‏
996 ‎‡2 CAOONL|ncf11280979‏
996 ‎‡2 NTA|327975989‏
996 ‎‡2 NTA|294716475‏
996 ‎‡2 LC|n 79081811‏
996 ‎‡2 ISNI|000000002819010X‏
996 ‎‡2 CAOONL|ncf10354306‏
996 ‎‡2 CAOONL|ncf11874593‏
996 ‎‡2 ISNI|0000000083346533‏
996 ‎‡2 NUKAT|n 2011221761‏
996 ‎‡2 J9U|987007349140705171‏
996 ‎‡2 SUDOC|182335135‏
996 ‎‡2 DNB|139827803‏
996 ‎‡2 LC|n 93077746‏
996 ‎‡2 LC|no 92030447‏
996 ‎‡2 BNE|XX5001893‏
996 ‎‡2 NII|DA15495654‏
996 ‎‡2 LC|n 91800737‏
996 ‎‡2 CAOONL|ncf11712247‏
996 ‎‡2 NUKAT|n 96208522‏
996 ‎‡2 LIH|LNB:B__ZM;=BP‏
996 ‎‡2 NTA|073492167‏
996 ‎‡2 J9U|987007263767205171‏
996 ‎‡2 NKC|utb2009525591‏
996 ‎‡2 NTA|068613563‏
996 ‎‡2 DBC|87097969545297‏
996 ‎‡2 ISNI|0000000031523999‏
996 ‎‡2 BNE|XX4580997‏
996 ‎‡2 NII|DA03927106‏
996 ‎‡2 BIBSYS|14040346‏
996 ‎‡2 LC|n 85290049‏
996 ‎‡2 ISNI|0000000025613170‏
996 ‎‡2 BNF|12055973‏
996 ‎‡2 NII|DA03566686‏
996 ‎‡2 BNF|12037820‏
996 ‎‡2 PLWABN|9810698706505606‏
996 ‎‡2 NSK|000546648‏
996 ‎‡2 ISNI|0000000071020181‏
996 ‎‡2 ISNI|0000000115612665‏
996 ‎‡2 NII|DA08902678‏
996 ‎‡2 SELIBR|193038‏
996 ‎‡2 CAOONL|ncf10021294‏
996 ‎‡2 BIBSYS|8048815‏
996 ‎‡2 LIH|LNB:C_w_4_d_;=B_y_‏
996 ‎‡2 DBC|87097969545289‏
996 ‎‡2 LC|n 95109602‏
996 ‎‡2 NUKAT|n 2012244444‏
996 ‎‡2 J9U|987007568487105171‏
996 ‎‡2 NUKAT|n 2011202405‏
996 ‎‡2 BNF|15737089‏
996 ‎‡2 PLWABN|9814295536905606‏
996 ‎‡2 J9U|987007263767505171‏
996 ‎‡2 CAOONL|ncf12097342‏
996 ‎‡2 LC|no2004060677‏
996 ‎‡2 BNF|14525119‏
996 ‎‡2 RERO|A013960899‏
996 ‎‡2 BIBSYS|90179528‏
996 ‎‡2 PLWABN|9810660420905606‏
996 ‎‡2 RERO|A009515288‏
996 ‎‡2 ISNI|0000000121244803‏
996 ‎‡2 ISNI|0000000119480057‏
996 ‎‡2 ISNI|0000000059899576‏
996 ‎‡2 SUDOC|082558523‏
996 ‎‡2 BNF|15026938‏
996 ‎‡2 NKC|pna2008424840‏
996 ‎‡2 NTA|106949039‏
996 ‎‡2 LC|no2003126830‏
996 ‎‡2 ISNI|000000007916223X‏
996 ‎‡2 J9U|987007263770405171‏
996 ‎‡2 J9U|987007475130805171‏
996 ‎‡2 DNB|1052513352‏
996 ‎‡2 J9U|987007347788105171‏
996 ‎‡2 CAOONL|ncf10423596‏
996 ‎‡2 DNB|139306633‏
996 ‎‡2 ISNI|0000000002913234‏
996 ‎‡2 CAOONL|ncf10699460‏
996 ‎‡2 DNB|140915583‏
996 ‎‡2 DNB|172181089‏
996 ‎‡2 SUDOC|139596720‏
996 ‎‡2 LC|n 2014077815‏
996 ‎‡2 NTA|07300314X‏
996 ‎‡2 BIBSYS|90943853‏
996 ‎‡2 ISNI|0000000027485491‏
996 ‎‡2 JPG|500338227‏
996 ‎‡2 ISNI|0000000083494640‏
996 ‎‡2 DNB|13866921X‏
996 ‎‡2 DNB|121842487‏
996 ‎‡2 SIMACOB|22659427‏
996 ‎‡2 SUDOC|144215586‏
996 ‎‡2 LIH|LNB:C,1_i_;=BO‏
996 ‎‡2 ISNI|0000000074452334‏
996 ‎‡2 BIBSYS|90103922‏
996 ‎‡2 LC|n 2022008359‏
996 ‎‡2 NYNYRILM|275276‏
996 ‎‡2 DNB|1189248298‏
996 ‎‡2 J9U|987007458857205171‏
996 ‎‡2 CAOONL|ncf11254518‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏